|
|
|
|
|
|
|
|
Conclusion: Our analysis suggested that among BRCA1/2 mutation carriers, prophylactic surgery would dominate or be cost effective compared to chemoprevention and screening. Annual screening with MRI and mammography was the most effective strategy because it was associated with the longest quality-adjusted survival, but it was also very expensive.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.